Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$1.74B |
| 2 |
Apple
AAPL
|
+$1.4B |
| 3 |
Micron Technology
MU
|
+$788M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$739M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$690M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.36B |
| 2 |
Bloom Energy
BE
|
+$1.22B |
| 3 |
Applied Materials
AMAT
|
+$1.17B |
| 4 |
Western Digital
WDC
|
+$1.16B |
| 5 |
Lam Research
LRCX
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.59% |
| 2 | Miscellaneous | 22.41% |
| 3 | Financials | 9.69% |
| 4 | Industrials | 8.9% |
| 5 | Healthcare | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FINV
3976
FinVolution Group
FINV
$803M
| $90.9K | ﹤0.01% |
18,970
+3,511
| +23% | +$17.4K |
|
|
TRTX
3977
TPG RE Finance Trust
TRTX
$593M
| $89.2K | ﹤0.01% |
10,396
-1
| -0% | -$8 |
|
3978
QuantumScape Corp
QS
$3.44B
| $86.9K | ﹤0.01% |
11,498
-1,792
| -13% | -$13.4K |
|
3979
Standard BioTools
LAB
$272M
| $86.2K | ﹤0.01% |
+104,805
| New | +$99K |
|
|
CLPR
3980
Clipper Realty
CLPR
$52.7M
| $86.2K | ﹤0.01% |
31,692
+10,892
| +52% | +$34.4K |
|
|
TIC
3981
TIC Solutions Inc
TIC
$2.09B
| $85.9K | ﹤0.01% |
10,612
-55
| -0.5% | -$464 |
|
3982
Genius Sports
GENI
$1.96B
| $85.7K | ﹤0.01% |
+14,145
| New | +$73.2K |
|
3983
SunCoke Energy
SXC
$868M
| $83.6K | ﹤0.01% |
10,390
-124,148
| -92% | -$959K |
|
3984
Prospect Capital
PSEC
$1.12B
| $82.8K | ﹤0.01% |
34,599
-8,879
| -20% | -$21.9K |
|
3985
CI&T Inc
CINT
$412M
| $81.1K | ﹤0.01% |
24,275
+644
| +3% | +$2.59K |
|
|
GRFS
3986
Grifois
GRFS
$5.27B
| $80.1K | ﹤0.01% |
+11,317
| New | +$89.4K |
|
3987
ACV Auctions
ACVA
$1.19B
| $76.4K | ﹤0.01% |
10,625
-7,658
| -42% | -$43.4K |
|
|
NB
3988
NioCorp Developments
NB
$600M
| $73.3K | ﹤0.01% |
15,203
-3,678
| -19% | -$20.1K |
|
|
UPB
3989
Upstream Bio Inc
UPB
$339M
| $72.6K | ﹤0.01% |
+10,487
| New | +$87.9K |
|
3990
Turkcell
TKC
$4.57B
| $72.4K | ﹤0.01% |
12,315
-3,239
| -21% | -$19.9K |
|
3991
BlackRock TCP Capital
TCPC
$341M
| $70.9K | ﹤0.01% |
21,089
+576
| +3% | +$2.24K |
|
3992
Latham Group
SWIM
$794M
| $69.2K | ﹤0.01% |
10,695
+527
| +5% | +$2.96K |
|
3993
TScan Therapeutics
TCRX
$23.4M
| $68.1K | ﹤0.01% |
69,487
+16,852
| +32% | +$18K |
|
|
HIVE
3994
HIVE Digital Technologies
HIVE
$864M
| $67.4K | ﹤0.01% |
+18,520
| New | +$59.8K |
|
3995
Ardelyx
ARDX
$973M
| $66.4K | ﹤0.01% |
13,023
+1,943
| +18% | +$11.9K |
|
3996
TriplePoint Venture Growth BDC
TPVG
$213M
| $65.1K | ﹤0.01% |
13,258
-4,308
| -25% | -$23.1K |
|
3997
Eos Energy Enterprises
EOSE
$1.57B
| $63.9K | ﹤0.01% |
+10,862
| New | +$75.5K |
|
3998
Pliant Therapeutics
PLRX
$70.6M
| $62.8K | ﹤0.01% |
55,129
| – | – |
|
3999
Cytek Biosciences
CTKB
$601M
| $62.6K | ﹤0.01% |
14,126
-173,144
| -92% | -$739K |
|
|
DHY
4000
UBS Asset Management High Yield Credit Fund
DHY
$235M
| $61.5K | ﹤0.01% |
34,545
+610
| +2% | +$1.09K |
|
Similar funds
Ameriprise's Q2 2026 Portfolio in Review
As of Q2 2026, Ameriprise held 4,288 positions worth $495B, up 15% from $432B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Ameriprise's Q2 2026 filing shows 236 new, 1,912 increased, 1,831 reduced and 191 closed positions. Its largest new stake was Honeywell Aerospace: 3,351,052 shares worth $741M. The largest sale was Marvell Technology, an estimated $2.36B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Financials.
- Ameriprise's largest Q2 2026 buy was Honeywell Aerospace: 3,351,052 shares worth $741M.
- Ameriprise added most to iShares Russell 1000 Value ETF in Q2 2026, an estimated $1.74B increase.
- Ameriprise's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.36B.
- Ameriprise fully exited Coterra Energy in Q2 2026, selling an estimated $63.9M.
- Ameriprise's ten largest holdings make up 20% of its $495B portfolio in Q2 2026.
- Ameriprise opened 236 new positions and closed 191 in Q2 2026.
- Ameriprise's portfolio value rose 15% quarter-over-quarter to $495B.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.